Royce & Associates LP Organon & Co. Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Organon & Co. stock. As of the latest transaction made, Royce & Associates LP holds 703,094 shares of OGN stock, worth $10.3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

703,094

Previous 672,344 4.57%

Holding current value

$10.3 Million

Previous $13.9 Million 3.36%

% of portfolio

0.13%

Previous 0.14%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$18.65 - $23.03 $573,487 - $708,172	30,750 Added 4.57%	703,094 $13.5 Million
Q2 2024 Aug 13, 2024	BUY	$17.45 - $21.96 $510,901 - $642,944	29,278 Added 4.55%	672,344 $13.9 Million
Q1 2024 May 13, 2024	BUY	$13.78 - $18.8 $198,404 - $270,682	14,398 Added 2.29%	643,066 $12.1 Million
Q4 2023 Feb 12, 2024	BUY	$10.95 - $17.32 $1.04 Million - $1.64 Million	94,600 Added 17.71%	628,668 $9.07 Million
Q3 2023 Nov 09, 2023	BUY	$16.59 - $23.77 $2.81 Million - $4.03 Million	169,630 Added 46.55%	534,068 $9.27 Million
Q2 2023 Aug 07, 2023	BUY	$19.27 - $24.63 $1.45 Million - $1.85 Million	75,083 Added 25.95%	364,438 $7.58 Million
Q1 2023 May 04, 2023	SELL	$21.42 - $32.08 $1.36 Million - $2.03 Million	-63,400 Reduced 17.97%	289,355 $6.81 Million
Q4 2022 May 23, 2023	BUY	$23.31 - $28.61 $1.48 Million - $1.81 Million	63,400 Added 21.91%	352,755 $9.86 Million
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $262,330 - $321,976	-11,254 Reduced 3.09%	352,755 $9.85 Million
Q3 2022 Nov 03, 2022	SELL	$23.4 - $34.25 $463,320 - $678,150	-19,800 Reduced 5.16%	364,009 $8.52 Million
Q2 2022 Aug 04, 2022	SELL	$31.66 - $38.9 $579,378 - $711,870	-18,300 Reduced 4.55%	383,809 $13 Million
Q1 2022 May 05, 2022	SELL	$30.45 - $39.36 $3.38 Million - $4.37 Million	-110,946 Reduced 21.62%	402,109 $14 Million
Q4 2021 Feb 07, 2022	SELL	$28.67 - $37.13 $212,158 - $274,762	-7,400 Reduced 1.42%	513,055 $15.6 Million
Q3 2021 Nov 10, 2021	SELL	$28.63 - $35.64 $754,343 - $939,042	-26,348 Reduced 4.82%	520,455 $17.1 Million
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $15.6 Million - $20.8 Million	546,803 New	546,803 $16.5 Million

Others Institutions Holding OGN

# of Institutions

793

Shares Held

192M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.74B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Organon & Co. Transaction History